{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:44:18Z","timestamp":1790858658631,"version":"4.1.0"},"reference-count":88,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.critrevonc.2010.10.005","type":"journal-article","created":{"date-parts":[[2010,11,10]],"date-time":"2010-11-10T09:39:34Z","timestamp":1289381974000},"page":"40-53","source":"Crossref","is-referenced-by-count":67,"title":["Trans-arterial chemoembolization as a therapy for liver tumours: New clinical developments and suggestions for combination with angiogenesis inhibitors"],"prefix":"10.1016","volume":"80","author":[{"given":"C. Damiano","family":"Gadaleta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girolamo","family":"Ranieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2010.10.005_bib0005","first-page":"203","article-title":"Hypoxic stop-flow perfusion with mitomycin-C in the treatment of multifocal liver metastases. Usefulness of a vascular arterial stent to prevent iatrogenic lesions of the hepatic arterial wall","volume":"4","author":"Gadaleta","year":"2003","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0010","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s00270-007-9280-6","article-title":"Drug-loaded microspheres for the treatment of liver cancer: review of current results","volume":"3","author":"Kettenbach","year":"2008","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"9","key":"10.1016\/j.critrevonc.2010.10.005_bib0015","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.jvir.2007.05.002","article-title":"Visualization of hepatic lymphatic vessels during transcatheter arterial chemoembolization for hepatocellular carcinoma","volume":"18","author":"Miyayama","year":"2007","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0020","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/1097-0142(19831215)52:12<2193::AID-CNCR2820521203>3.0.CO;2-R","article-title":"Studies on anticancer treatment with an oily anticancer drug injected into the ligated feeding hepatic artery for liver cancer","volume":"52","author":"Nakakuma","year":"1983","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0025","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1097\/00004424-199411000-00007","article-title":"Role of Kupffer cells in iodized oil embolization","volume":"29","author":"Kan","year":"1994","journal-title":"Invest Radiol"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0030","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1365-2354.2008.00984.x","article-title":"A randomized controlled trial of transcatheter arterial chemoembolization with lipiodol, doxorubicin and cisplatin versus intravenous doxorubicin for patients with unresectable hepatocellular carcinoma","volume":"5","author":"Mabed","year":"2009","journal-title":"Eur J Cancer Care"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0035","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1148\/radiology.170.3.2536946","article-title":"Transcatheter oily chemoembolization of hepatocellular carcinoma","volume":"170","author":"Nakamura","year":"1989","journal-title":"Radiology"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0040","first-page":"1349","article-title":"Pharmacokinetic study of adriamycin in the emulsion mixed with Lipiodol-difference resulting from composition and methods of preparation, and behavior after mesenteric arterial injection in rat","volume":"18","author":"Sakaguchi","year":"1991","journal-title":"Gan To Kagaku Ryoho"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0045","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/1097-0142(19920801)70:3<585::AID-CNCR2820700308>3.0.CO;2-#","article-title":"Chemoembolization of hepatocellular carcinomas. A study of the biodistribution and pharmacokinetics of doxorubicin","volume":"70","author":"Raoul","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0050","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s00270-006-0062-3","article-title":"Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies","volume":"30","author":"Marelli","year":"2007","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"5","key":"10.1016\/j.critrevonc.2010.10.005_bib0055","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3348\/kjr.2009.10.5.425","article-title":"The current practice of transarterial chemoembolization for the treatment of hepatocellular carcinoma","volume":"10","author":"Shin","year":"2009","journal-title":"Korean J Radiol"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0060","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1148\/radiology.156.2.2989972","article-title":"Bile duct necrosis: complication of transcatheter hepatic arterial embolization","volume":"156","author":"Makuuchi","year":"1985","journal-title":"Radiology"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0065","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1148\/radiographics.14.3.8066276","article-title":"Embolotherapy: agents, clinical applications, and techniques","volume":"14","author":"Coldwell","year":"1994","journal-title":"Radiographics"},{"issue":"2","key":"10.1016\/j.critrevonc.2010.10.005_bib0070","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/01.RVI.0000195323.46152.B3","article-title":"DC bead: in vitro characterization of a drug-delivery device for transarterial chemoembolization","volume":"17","author":"Lewis","year":"2006","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0075","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1586\/erd.09.20","article-title":"DC Bead: a major development in the toolbox for the interventional oncologist","volume":"4","author":"Lewis","year":"2009","journal-title":"Expert Rev Med Devices"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0080","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2174\/1568011013354723","article-title":"Anthracyclines: selected new developments","volume":"1","author":"Binaschi","year":"2001","journal-title":"Curr Med Chem Anticancer Agents"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0085","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000264620","article-title":"Application of DC beads in hepatocellular carcinoma: clinical and radiological results of a drug delivery device for transcatheter superselective arterial embolization","volume":"33","author":"Sadick","year":"2010","journal-title":"Onkologie"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0090","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/bmc.1345","article-title":"Irinotecan and its active metabolite, SN-38: review of bioanalytical methods and recent update from clinical pharmacology perspectives","volume":"24","author":"Ramesh","year":"2010","journal-title":"Biomed Chromatogr"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0095","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/1078155209337650","article-title":"Stability of irinotecan-loaded drug eluting beads (DC Bead) used for transarterial chemoembolization","volume":"16","author":"Kaiser","year":"2010","journal-title":"J Oncol Pharm Pract"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0100","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1158\/1078-0432.CCR-05-2225","article-title":"New intra-arterial drug delivery system for the treatment of liver cancer: preclinical assessment in a rabbit model of liver cancer","volume":"12","author":"Hong","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0105","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/01.RVI.0000228416.21560.7F","article-title":"Pharmacokinetic and safety study of doxorubicin-eluting beads in a porcine model of hepatic arterial embolization","volume":"8","author":"Lewis","year":"2006","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0110","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00270-007-9240-1","article-title":"In vivo evaluation of a new embolic spherical particle (HepaSphere) in a kidney animal model","volume":"2","author":"de Luis","year":"2008","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"3","key":"10.1016\/j.critrevonc.2010.10.005_bib0115","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s10585-008-9142-x","article-title":"Chemoembolisation of rat colorectal liver metastases with drug eluting beads loaded with irinotecan or doxorubicin","volume":"25","author":"Eyol","year":"2008","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0120","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.jvir.2008.08.027","article-title":"Do microspheres with narrow or standard size distributions localize differently in vasculature? An experimental study in sheep kidney and uterus","volume":"12","author":"Laurent","year":"2008","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0125","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1634\/theoncologist.2008-0142","article-title":"Chemotherapy for colorectal cancer liver metastases","volume":"10","author":"Alberts","year":"2008","journal-title":"Oncologist"},{"issue":"7","key":"10.1016\/j.critrevonc.2010.10.005_bib0130","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s00117-004-1061-5","article-title":"Transarterial chemoembolization of liver metastases of colorectal carcinoma using degradable starch microspheres (Spherex): personal investigations and review of the literature","volume":"45","author":"Wasser","year":"2005","journal-title":"Radiologe"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0135","first-page":"3793","article-title":"Trans-arterial chemoembolization (TACE) of liver metastases from colorectal cancer using irinotecan-eluting beads: preliminary results","volume":"26","author":"Aliberti","year":"2006","journal-title":"Anticancer Res"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0140","first-page":"1085","article-title":"Intraarterial hepatic chemoembolization of livermetastases from colorectal cancer adopting irinotecan-eluting beads: results of a phase II clinical study","volume":"6","author":"Fiorentini","year":"2007","journal-title":"In Vivo"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0145","first-page":"2077","article-title":"TACE of liver metastases from colorectal cancer adopting irinotecan-eluting beads: beneficial effect of palliative intra-arterial lidocaine and post-procedure supportive therapy on the control of side effects","volume":"88","author":"Fiorentini","year":"2008","journal-title":"Hepatogastroenterology"},{"issue":"6B","key":"10.1016\/j.critrevonc.2010.10.005_bib0150","first-page":"3835","article-title":"Transhepatic arterial chemoembolization with oxaliplatin-eluting microspheres (OEM-TACE) for unresectable hepatic tumors","volume":"28","author":"Poggi","year":"2008","journal-title":"Anticancer Res"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0155","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1001\/jama.255.22.3152","article-title":"Treatment of hepatic metastases in ocular melanoma. Embolization of the hepatic artery with polyvinyl sponge and cisplatin","volume":"22","author":"Carrasco","year":"1986","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.critrevonc.2010.10.005_bib0160","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1001\/jama.260.7.974","article-title":"Regression of ocular melanoma metastatic to the liver after hepatic arterial chemoembolization with cisplatin and polyvinyl sponge","volume":"260","author":"Mavligit","year":"1988","journal-title":"JAMA"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0165","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/01.cmr.0000129377.22141.ea","article-title":"Phase I\/II randomized trial of intrahepatic arterial infusion chemotherapy with cisplatin and chemoembolization with cisplatin and polyvinyl sponge in patients with ocular melanoma metastatic to the liver","volume":"14","author":"Agarwala","year":"2004","journal-title":"Melanoma Res"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0170","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00008390-200508000-00011","article-title":"Chemoembolization of the hepatic artery with BCNU for metastatic uveal melanoma: results of a phase II study","volume":"15","author":"Patel","year":"2005","journal-title":"Melanoma Res"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0175","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00432-006-0155-z","article-title":"Preliminary experience with transarterial chemoembolization (TACE) in liver metastases of uveal malignant melanoma: local tumor control and survival","volume":"133","author":"Vogl","year":"2007","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0180","first-page":"131","article-title":"Intra-arterial hepatic chemoembolization (TACE) of liver metastases from ocular melanoma with slow-release irinotecan-eluting beads. Early results of a phase II clinical study","volume":"23","author":"Fiorentini","year":"2009","journal-title":"In Vivo"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0185","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1677\/ERC-08-0301","article-title":"Prognostic factors influencing survival from metastatic (stage IV) gastroenteropancreatic well-differentiated endocrine carcinoma","volume":"2","author":"Durante","year":"2009","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0190","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s00330-002-1558-0","article-title":"Trans-catheter arterial chemoembolization as first-line treatment for hepatic metastases from endocrine tumors","volume":"1","author":"Roche","year":"2003","journal-title":"Eur Radiol"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0195","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jvir.2008.01.030","article-title":"Transarterial chemoembolization of liver metastases from well differentiated gastroenteropancreatic endocrine tumors with doxorubicin-eluting beads: preliminary results","volume":"6","author":"de Baere","year":"2008","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0200","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S1470-2045(09)70029-4","article-title":"Hepatic complications of breast cancer","volume":"6","author":"Diamond","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0205","doi-asserted-by":"crossref","first-page":"3782","DOI":"10.3748\/wjg.v11.i24.3782","article-title":"Treatment for liver metastases from breast cancer: results and prognostic factors","volume":"11","author":"Li","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0210","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00330-009-1525-0","article-title":"Transarterial chemoembolization (TACE) with mitomycin C and gemcitabine for liver metastases in breast cancer","volume":"20","author":"Vogl","year":"2010","journal-title":"Eur Radiol"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0215","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1007\/s00330-008-0887-z","article-title":"Repetitive transarterial chemoembolization (TACE) of liver metastases from renal cell carcinoma: local control and survival results","volume":"18","author":"Nabil","year":"2008","journal-title":"Eur Radiol"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0220","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.3748\/wjg.15.4240","article-title":"Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990\u20132009","volume":"15","author":"Aljiffry","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0225","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11605-007-0312-y","article-title":"Treatment of unresectable cholangiocarcinoma with gemcitabine-based transcatheter arterial chemoembolization (TACE): a single-institution experience","volume":"12","author":"Gusani","year":"2008","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0230","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s00270-008-9336-2","article-title":"Chemoembolization (TACE) of unresectable intrahepatic cholangiocarcinoma with slow-release doxorubicin-eluting beads: preliminary results","volume":"31","author":"Aliberti","year":"2008","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0235","first-page":"29","article-title":"OEM-TACE: a new therapeutic approach in unresectable intrahepatic cholangiocarcinoma","author":"Poggi","year":"2009","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0240","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3348\/kjr.2009.10.5.425","article-title":"The current practice of transarterial chemoembolization for the treatment of hepatocellular carcinoma","volume":"10","author":"Shin","year":"2009","journal-title":"Korean J Radiol"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0245","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1365-2036.2007.03395.x","article-title":"Predictors of outcome in patients with unresectable hepatocellular carcinoma receiving transcatheter arterial chemoembolization","volume":"26","author":"Shen","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0250","doi-asserted-by":"crossref","first-page":"4582","DOI":"10.3748\/wjg.15.4582","article-title":"Effect of preoperative transcatheter arterial chemoembolization on angiogenesis of hepatocellular carcinoma cells","volume":"15","author":"Xiao","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0255","first-page":"1539","article-title":"The effect of doxorubicin on the changes of serum vascular endothelial growth factor (VEGF) in patients with hepatocellular carcinoma after transcatheter arterial chemoembolization (TACE)","volume":"91","author":"Leelawat","year":"2008","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0260","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00270-007-9226-z","article-title":"Transarterial chemoembolization of unresectable hepatocellular carcinoma with drug eluting beads: results of an open-label study of 62 patients","volume":"31","author":"Malagari","year":"2008","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0265","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1093\/jjco\/hyn076","article-title":"Treatment of hepatocellular carcinoma using arterial chemoembolization with degradable starch microspheres and continuous arterial infusion of 5-fluorouracil","volume":"38","author":"Ishida","year":"2008","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0270","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s00270-008-9409-2","article-title":"Transarterial chemoembolization for hepatocellular carcinoma with drug-eluting microspheres: preliminary results from an Italian multicentre study","volume":"31","author":"Grosso","year":"2008","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0275","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.2174\/092986706777585059","article-title":"Vascular endothelial growth factor (VEGF) as a target of bevacizumab in cancer: from the biology to the clinic","volume":"13","author":"Ranieri","year":"2006","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0280","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.3748\/wjg.v9.i11.2445","article-title":"Influence of transarterial chemoembolization on angiogenesis and expression of vascular endothelial growth factor and basic fibroblast growth factor in rat with Walker-256 transplanted hepatoma: an experimental study","volume":"9","author":"Li","year":"2003","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0285","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1080\/02841850801958890","article-title":"Increased expression of vascular endothelial growth factor in hepatocellular carcinoma after transcatheter arterial chemoembolization","volume":"49","author":"Wang","year":"2008","journal-title":"Acta Radiol"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0290","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1111\/j.1349-7006.2008.00909.x","article-title":"Association between increment of serum VEGF level and prognosis after transcatheter arterial chemoembolization in hepatocellular carcinoma patients","volume":"99","author":"Shim","year":"2008","journal-title":"Cancer Sci"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0295","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/j.1572-0241.2007.01712.x","article-title":"Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): the role of angiogenesis and invasiveness","volume":"103","author":"Sergio","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0300","first-page":"386","article-title":"Association between vascular endothelial growth factor and metastasis after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma","volume":"3","author":"Xiong","year":"2004","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0305","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.3748\/wjg.v10.i19.2878","article-title":"Expression of plasma vascular endothelial growth factor in patients with hepatocellular carcinoma and effect of transcatheter arterial chemoembolization therapy on plasma vascular endothelial growth factor level","volume":"10","author":"Li","year":"2004","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0310","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s11596-007-0117-y","article-title":"Relationship between the changes of VEGF level and dendritic cells in peripheral blood of patients with hepatocellular carcinoma after transcatheter arterial chemoembolization","volume":"27","author":"Liu","year":"2007","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0315","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0320","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1470-2045(08)70285-7","article-title":"Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial","volume":"10","author":"Cheng","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0325","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2165\/00003495-200868020-00007","article-title":"Sorafenib: in hepatocellular carcinoma","volume":"68","author":"Simpson","year":"2008","journal-title":"Drugs"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0330","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1186\/1471-2407-8-349","volume":"8","author":"Hoffmann","year":"2008","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0335","unstructured":"Chao Y, Yoon J, Li C, et al. START: Study in Asia of the combination of TACE (transcatheter arterial chemoembolization) with sorafenib in patients with hepatocellular carcinoma trial. 2010 Gastrointestinal Cancers Symposium."},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0340","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/sj.bjc.6604784","article-title":"Molecular therapy for the treatment of hepatocellular carcinoma","volume":"100","author":"Greten","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0345","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1634\/theoncologist.2009-0316","article-title":"Continuous Sunitinib treatment in patients with advanced hepatocellular carcinoma: a Swiss Group for Clinical Cancer Research (SAKK) and Swiss Association for the Study of the Liver (SASL) multicenter phase II trial (SAKK 77\/06)","volume":"15","author":"Koeberle","year":"2010","journal-title":"Oncologist"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0350","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1582-4934.2008.00355.x","article-title":"VEGF concentration from plasma-activated platelets rich correlates with microvascular density and grading in canine mast cell tumour spontaneous model","volume":"13","author":"Patruno","year":"2009","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0355","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2174\/187153006778250028","article-title":"Drug targets to pro-angiogenetic factors with special reference to primary peritoneal mesothelioma","volume":"6","author":"Ranieri","year":"2006","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0360","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1200\/JCO.2007.15.9947","article-title":"Phase II trial evaluating the clinical and biologic effects of bevacizumab in unresectable hepatocellular carcinoma","volume":"26","author":"Siegel","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0365","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/sj.bjc.6605580","article-title":"Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma","volume":"102","author":"Hsu","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0370","doi-asserted-by":"crossref","unstructured":"Reyes DK, Vossen JA, Kamel IR, et al. Phase II trial of bevacizumab combined with transarterial chemoembolization (TACE) for hepatocellular carcinoma: initial experience at two institutions. 2010 Gastrointestinal Cancers Symposium.","DOI":"10.1016\/j.jvir.2009.12.295"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0375","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0380","first-page":"1388","article-title":"Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies","volume":"60","author":"Eberhard","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0385","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.critrevonc.2007.01.002","article-title":"Angiogenesis inhibitors in the treatment of lung cancer","volume":"62","author":"Sun","year":"2007","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0390","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.critrevonc.2009.06.001","article-title":"Clinical relevance of contrast-enhanced ultrasound in monitoring anti-angiogenic therapy of cancer: current status and perspectives","volume":"73","author":"Lamuraglia","year":"2010","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0395","first-page":"1706","article-title":"Oncological applications of FDGPET imaging","volume":"40","author":"Delbeke","year":"1999","journal-title":"J Nucl Med"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0400","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S","article-title":"Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusible tracer: standardized quantities and symbols","volume":"10","author":"Tofts","year":"1999","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0405","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1148\/radiology.210.1.r99ja46269","article-title":"Regional blood flow, capillary permeability, and compartmental volumes: measurement with dynamic CT\u2014initial experience","volume":"210","author":"Brix","year":"1999","journal-title":"Radiology"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0410","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1148\/radiol.2392040986","article-title":"Angiogenesis: noninvasive quantitative assessment with contrast-enhanced functional US in murine model","volume":"239","author":"Lucidarme","year":"2006","journal-title":"Radiology"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0415","first-page":"769","article-title":"Stop-flow perfusion with mitomycin-C as locoregional approach in the treatment of large-unresectable liver metastases","volume":"20","author":"Gadaleta","year":"2006","journal-title":"In Vivo"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0420","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1477-7819-7-80","article-title":"Transarterial chemoembolisation (TACE) using irinotecan-loaded beads for the treatment of unresectable metastases to the liver in patients with colorectal cancer: an interim report","volume":"7","author":"Martin","year":"2009","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0425","first-page":"813","article-title":"Single-step therapy feasibility and safety of simultaneous transarterial chemoembolization and radiofrequency ablation for hepatic malignancies","volume":"23","author":"Gadaleta","year":"2009","journal-title":"In Vivo"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0430","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/PPO.0b013e31816a0fac","article-title":"Radiofrequency ablation and chemoembolization for hepatocellular carcinoma","volume":"14","author":"Georgiades","year":"2008","journal-title":"Cancer J"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0435","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3892\/ijo_00000319","article-title":"Tryptase-positive mast cells correlate with angiogenesis in early breast cancer patients","volume":"35","author":"Ranieri","year":"2009","journal-title":"Int J Oncol"},{"key":"10.1016\/j.critrevonc.2010.10.005_bib0440","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1582-4934.2007.00007.x","article-title":"A possible role of thymidine phosphorylase expression and 5-fluorouracil increased sensitivity in oropharyngeal cancer patients","volume":"11","author":"Ranieri","year":"2007","journal-title":"J Cell Mol Med"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842810002416?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842810002416?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T03:10:18Z","timestamp":1711941018000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842810002416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":88,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S1040842810002416"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2010.10.005","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}